Keywords: Novartis, Alcon, Competition, Divestments, USA, China

Novartis buy of Alcon moves forward, but USA and China competition authorities call for divestments

Article | 17 August 2010

Print This

Swiss drug major Novartis will be required to sell an injectable eye care drug used in cataract surgery as part ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in